Distortion-free enhancement of terahertz signals measured by electro-optic sampling. I. Theory

We present three methods for the distortion-free enhancement of THz signals measured by electro-optic sampling in zinc blende-type detector crystals, e.g., ZnTe or GaP. A technique commonly used in optically heterodyne-detected optical Kerr effect spectroscopy is introduced, which is based on two measurements at opposite optical biases near the zero transmission point in a crossed polarizer detection geometry. In contrast to other techniques for an undistorted THz signal enhancement, it also works in a balanced detection scheme and does not require an elaborate procedure for the reconstruction of the true signal as the two measured waveforms are simply subtracted to remove distortions. We study three different approaches for setting an optical bias using the Jones matrix formalism and discuss them also in the framework of optical heterodyne detection. We show that there is an optimal bias point in realistic situations where a small fraction of the probe light is scattered by optical components. The experimental demonstration will be given in the second part of this two-paper series [J. Opt. Soc. Am. B, doc. ID 204877 (2014, posted online)].

Multimorbidity and quality of preventive care in Swiss university primary care cohorts.

BACKGROUND Caring for patients with multimorbidity is common for generalists, although such patients are often excluded from clinical trials, and thus such trials lack of generalizability. Data on the association between multimorbidity and preventive care are limited. We aimed to assess whether comorbidity number, severity and type were associated with preventive care among patients receiving care in Swiss University primary care settings. METHODS We examined a retrospective cohort composed of a random sample of 1,002 patients aged 50-80 years attending four Swiss university primary care settings. Multimorbidity was defined according to the literature and the Charlson index. We assessed the quality of preventive care and cardiovascular preventive care with RAND's Quality Assessment Tool indicators. Aggregate scores of quality of provided care were calculated by taking into account the number of eligible patients for each indicator. RESULTS Participants (mean age 63.5 years, 44% women) had a mean of 2.6 (SD 1.9) comorbidities and 67.5% had 2 or more comorbidities. The mean Charlson index was 1.8 (SD 1.9). Overall, participants received 69% of recommended preventive care and 84% of cardiovascular preventive care. Quality of care was not associated with higher numbers of comorbidities, both for preventive care and for cardiovascular preventive care. Results were similar in analyses using the Charlson index and after adjusting for age, gender, occupation, center and number of visits. Some patients may receive less preventive care including those with dementia (47%) and those with schizophrenia (35%). CONCLUSIONS In Swiss university primary care settings, two thirds of patients had 2 or more comorbidities. The receipt of preventive and cardiovascular preventive care was not affected by comorbidity count or severity, although patients with certain comorbidities may receive lower levels of preventive care.

Patient and physician gender concordance in preventive care in university primary care settings.

OBJECTIVE To assess the quality of preventive care according to physician and patient gender in a country with universal health care coverage. METHODS We assessed a retrospective cohort study of 1001 randomly selected patients aged 50-80 years followed over 2 years (2005-2006) in 4 Swiss university primary care settings (Basel, Geneva, Lausanne, Zürich). We used indicators derived from RAND's Quality Assessment Tools and examined percentages of recommended preventive care. Results were adjusted using hierarchical multivariate logistic regression models. RESULTS 1001 patients (44% women) were followed by 189 physicians (52% women). Female patients received less preventive care than male patients (65.2% vs. 72.1%, p<0.001). Female physicians provided significantly more preventive care than male physicians (p=0.01) to both female (66.7% vs. 63.6%) and male patients (73.4% vs. 70.7%). After multivariate adjustment, differences according to physician (p=0.02) and patient gender (p<0.001) remained statistically significant. Female physicians provided more recommended cancer screening than male physicians (78.4 vs. 71.9%, p=0.01). CONCLUSIONS In Swiss university primary care settings, female patients receive less preventive care than male patients, with female physicians providing more preventive care than male physicians. Greater attention should be paid to female patients in preventive care and to why female physicians tend to provide better preventive care.

Clinically relevant quality measures for risk factor control in primary care: a retrospective cohort study

BACKGROUND Assessment of the proportion of patients with well controlled cardiovascular risk factors underestimates the proportion of patients receiving high quality of care. Evaluating whether physicians respond appropriately to poor risk factor control gives a different picture of quality of care. We assessed physician response to control cardiovascular risk factors, as well as markers of potential overtreatment in Switzerland, a country with universal healthcare coverage but without systematic quality monitoring, annual report cards on quality of care or financial incentives to improve quality. METHODS We performed a retrospective cohort study of 1002 randomly selected patients aged 50-80 years from four university primary care settings in Switzerland. For hypertension, dyslipidemia and diabetes mellitus, we first measured proportions in control, then assessed therapy modifications among those in poor control. "Appropriate clinical action" was defined as a therapy modification or return to control without therapy modification within 12 months among patients with baseline poor control. Potential overtreatment of these conditions was defined as intensive treatment among low-risk patients with optimal target values. RESULTS 20% of patients with hypertension, 41% with dyslipidemia and 36% with diabetes mellitus were in control at baseline. When appropriate clinical action in response to poor control was integrated into measuring quality of care, 52 to 55% had appropriate quality of care. Over 12 months, therapy of 61% of patients with baseline poor control was modified for hypertension, 33% for dyslipidemia, and 85% for diabetes mellitus. Increases in number of drug classes (28-51%) and in drug doses (10-61%) were the most common therapy modifications. Patients with target organ damage and higher baseline values were more likely to have appropriate clinical action. We found low rates of potential overtreatment with 2% for hypertension, 3% for diabetes mellitus and 3-6% for dyslipidemia. CONCLUSIONS In primary care, evaluating whether physicians respond appropriately to poor risk factor control, in addition to assessing proportions in control, provide a broader view of the quality of care than relying solely on measures of proportions in control. Such measures could be more clinically relevant and acceptable to physicians than simply reporting levels of control.

Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.

The consumption of immunoglobulins (Ig) is increasing due to better recognition of antibody deficiencies, an aging population, and new indications. This review aims to examine the various dosing regimens and research developments in the established and in some of the relevant off-label indications in Europe. The background to the current regulatory settings in Europe is provided as a backdrop for the latest developments in primary and secondary immunodeficiencies and in immunomodulatory indications. In these heterogeneous areas, clinical trials encompassing different routes of administration, varying intervals, and infusion rates are paving the way toward more individualized therapy regimens. In primary antibody deficiencies, adjustments in dosing and intervals will depend on the clinical presentation, effective IgG trough levels and IgG metabolism. Ideally, individual pharmacokinetic profiles in conjunction with the clinical phenotype could lead to highly tailored treatment. In practice, incremental dosage increases are necessary to titrate the optimal dose for more severely ill patients. Higher intravenous doses in these patients also have beneficial immunomodulatory effects beyond mere IgG replacement. Better understanding of the pharmacokinetics of Ig therapy is leading to a move away from simplistic "per kg" dosing. Defective antibody production is common in many secondary immunodeficiencies irrespective of whether the causative factor was lymphoid malignancies (established indications), certain autoimmune disorders, immunosuppressive agents, or biologics. This antibody failure, as shown by test immunization, may be amenable to treatment with replacement Ig therapy. In certain immunomodulatory settings [e.g., idiopathic thrombocytopenic purpura (ITP)], selection of patients for Ig therapy may be enhanced by relevant biomarkers in order to exclude non-responders and thus obtain higher response rates. In this review, the developments in dosing of therapeutic immunoglobulins have been limited to high and some medium priority indications such as ITP, Kawasaki' disease, Guillain-Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy, myasthenia gravis, multifocal motor neuropathy, fetal alloimmune thrombocytopenia, fetal hemolytic anemia, and dermatological diseases.

Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: "STROBE-RDS" statement.

OBJECTIVES Respondent-driven sampling (RDS) is a new data collection methodology used to estimate characteristics of hard-to-reach groups, such as the HIV prevalence in drug users. Many national public health systems and international organizations rely on RDS data. However, RDS reporting quality and available reporting guidelines are inadequate. We carried out a systematic review of RDS studies and present Strengthening the Reporting of Observational Studies in Epidemiology for RDS Studies (STROBE-RDS), a checklist of essential items to present in RDS publications, justified by an explanation and elaboration document. STUDY DESIGN AND SETTING We searched the MEDLINE (1970-2013), EMBASE (1974-2013), and Global Health (1910-2013) databases to assess the number and geographical distribution of published RDS studies. STROBE-RDS was developed based on STROBE guidelines, following Guidance for Developers of Health Research Reporting Guidelines. RESULTS RDS has been used in over 460 studies from 69 countries, including the USA (151 studies), China (70), and India (32). STROBE-RDS includes modifications to 12 of the 22 items on the STROBE checklist. The two key areas that required modification concerned the selection of participants and statistical analysis of the sample. CONCLUSION STROBE-RDS seeks to enhance the transparency and utility of research using RDS. If widely adopted, STROBE-RDS should improve global infectious diseases public health decision making.

Einfluss von relativer Luftfeuchtigkeit und Applikationszeit auf die Dentinhaftkraft von sechs verschiedenen Adhäsivsystemen

Einleitung und Ziel: Das Arbeiten mit Adhäsivsystemen und Kompositmaterialien ist techniksensitiv und oft auch zeitaufwändig. Adhäsivsysteme und Kompositmaterialien sind feuchtigkeitsanfällig, weswegen die Verwendung eines Kofferdams von den Herstellern empfohlen wird - nicht nur, um während des Arbeitens mit Adhäsivsystemen und Kompositmaterialien die Gefahr einer Blut- oder Speichelkontamination zu minimieren sondern auch, um die hohe relative Luftfeuchtigkeit in der Mundhöhle auf die Luftfeuchtigkeit der Umgebung zu reduzieren. Abgesehen davon bestehen viele Adhäsivsysteme aus mehreren Applikationsschritten und diese Applikationsschritte weisen jeweils von den Herstellern genau angegebene Applikationszeiten auf. Je nach Adhäsivsystem erscheinen diese Applikationszeiten relativ lang und im klinischen Alltag kann die Gefahr bestehen, dass es zu einer Reduktion der vom Hersteller angegeben Applikationszeiten kommt. Es ist sehr wahrscheinlich, dass sowohl erhöhte relative Luftfeuchtigkeit als auch reduzierte Applikationszeiten die Dentinhaftkraft von Adhäsivsystemen negativ beeinflussen. Das Ziel dieser Studie war folglich, den Einfluss von relativer Luftfeuchtigkeit und Applikationszeit auf die Dentinhaftkraft von sechs verschiedenen Adhäsivsystemen zu untersuchen. Material und Methoden: Insgesamt 360 extrahierte menschliche Molaren ohne Füllungen und/oder Karies wurden verwendet (n=15 pro Gruppe; 24 Gruppen). Die Molaren wurden gereinigt und von okklusal bis ins mittlere Zahnkronendentin plangeschliffen. Die plangeschliffenen Molaren wurden anschliessend in selbsthärtendem Kunststoff eingebettet. Danach wurden die Oberflächen des Zahnkronendentins mit einem von sechs Adhäsivsystemen behandelt und Komposit (Filtek Z250; 3M ESPE) in Form eines Zylinders appliziert. Die sechs Adhäsivsysteme umfassten: 1) Syntac Classic (Ivoclar Vivadent), 2) OptiBond FL (Kerr), 3) Clearfil SE Bond (Kuraray), 4) AdheSE (Ivoclar Vivadent), 5) Xeno Select (DENTSPLY DeTrey) sowie 6) Scotchbond Universal (3M ESPE). Die Applikation des Adhäsivsystems und des Kompositzylinders wurde unter vier experimentellen Bedingungen durchgeführt. Die vier experimentellen Bedingungen wurden in einer modifizierten Handschuhbox erstellt (Abb. 1; CSL-GB24, Cleaver Scientific, Rugby, Grossbritannien) und umfassten: a) relative Luftfeuchtigkeit der Umgebung (~45%) und Applikationszeit gemäss Herstellerangaben, b) relative Luftfeuchtigkeit der Umgebung (~45%) und reduzierte Applikationszeit, c) erhöhte relative Luftfeuchtigkeit (≥85%) und Applikationszeit gemäss Herstellerangaben sowie d) erhöhte relative Luftfeuchtigkeit (≥85%) und reduzierte Applikationszeit. Nach 24 Stunden Lagerung wurden die auf Dentin applizierten Kompositzylinder in einer Universalprüfmaschine (Abb. 2; zwicki Z1.0 TN, Zwick, Ulm, Deutschland) mittels Scherkrafttest belastet (Traversengeschwindigkeit: 1 mm/min) und so die Haftkraftwerte bestimmt. Die Haftkraftwerte wurden anschliessend mit einer nichtparametrischen Varianzanalyse statistisch analysiert, gefolgt von Kruskal-Wallis- und Mann Whitney U-Tests sowie einer Bonferroni-Holm Korrektur für multiples Testen. Das Signifikanzniveau wurde auf α = 0.05 festgelegt. Resultate: Erhöhte relative Luftfeuchtigkeit sowie reduzierte Applikationszeit hatten keinen signifikanten Einfluss auf die Haftkraft von zwei der sechs untersuchten Adhäsivsysteme (Clearfil SE Bond und Scotchbond Universal; p = 1.00). Die Haftkraft der anderen vier Adhäsivsysteme (Syntac Classic, OptiBond FL, AdheSE und Xeno Select) wurde durch eine reduzierte Applikationszeit nicht signifikant beeinflusst (p ≥ 0.403). Allerdings reduzierte eine erhöhte relative Luftfeuchtigkeit (ungeachtet der Applikationszeit) die Haftkraft von Syntac Classic, OptiBond FL und Xeno Select signifikant (p ≤ 0.003). Eine erhöhte relative Luftfeuchtigkeit reduzierte die Haftkraft von AdheSE nur dann signifikant, wenn das Adhäsivsystem mit Applikationszeit gemäss Herstellerangaben verwendet wurde (p = 0.002). Hinsichtlich Unterschiede in der Haftkraft zwischen den sechs Adhäsivsystemen zeigte sich, dass OptiBond FL und Scotchbond Universal generell (sprich ungeachtet der vier experimentellen Bedingungen) die höchste Haftkraft erzielten. Von den anderen vier Adhäsivsystemen wurde Clearfil SE Bond am wenigsten durch erhöhte relative Luftfeuchtigkeit oder reduzierte Applikationszeit beeinflusst und zeigte zwar niedrigere Haftkraftwerte im Vergleich zu OptiBond FL und Scotchbond Universal dafür aber die konstanteste Haftkraft unter allen vier experimentellen Bedingungen. Schlussfolgerung: Die Dentinhaftkraft von zwei der sechs untersuchten Adhäsivsysteme (Clearfil SE Bond und Scotchbond Universal) wurde weder durch erhöhte relative Luftfeuchtigkeit noch durch reduzierte Applikationszeiten beeinflusst. Die Haftkraft der anderen vier Adhäsivsysteme wurde vor allem durch eine erhöhte relative Luftfeuchtigkeit negativ beeinflusst, grossmehrheitlich aber nicht durch eine reduzierte Applikationszeit. Klinisch ist daher die Kontrolle und Reduktion der relativen Luftfeuchtigkeit durch die Verwendung eines Kofferdams sehr zu empfehlen. Obwohl diese Studie gezeigt hat, dass reduzierte Applikationszeiten einen weniger starken, negativen Einfluss auf die Haftkraft haben, ist es trotzdem angezeigt, die Gebrauchsanleitungen der Adhäsivsysteme zu befolgen und sich an die Herstellerangaben zu halten.

'Choosing Wisely': a growing international campaign.

Much attention has been paid to the inappropriate underuse of tests and treatments but until recently little attention has focused on the overuse that does not add value for patients and may even cause harm. Choosing Wisely is a campaign to engage physicians and patients in conversations about unnecessary tests, treatments and procedures. The campaign began in the United States in 2012, in Canada in 2014 and now many countries around the world are adapting the campaign and implementing it. This article describes the present status of Choosing Wisely programs in 12 countries. It articulates key elements, a set of five principles, and describes the challenges countries face in the early phases of Choosing Wisely. These countries plan to continue collaboration including developing metrics to measure overuse.